BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 6729733)

  • 1. [Effect of cardiac glycosides and anabolic preparations on the indices of the blood oxygen balance and carbohydrate metabolism in ischemic heart disease patients in the initial (preclinical) stage of heart failure].
    Denisiuk VI; Shkliar MB
    Ter Arkh; 1984; 56(4):64-7. PubMed ID: 6729733
    [No Abstract]   [Full Text] [Related]  

  • 2. [Role of microcirculatory hemodynamics, blood oxygen balance and carbohydrate metabolism in the pathogenesis of the initial (preclinical) stage of heart failure in ischemic heart disease].
    Denisiuk VI
    Ter Arkh; 1985; 57(1):46-9. PubMed ID: 3983843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Peripheral vasodilators in the treatment of chronic circulatory failure in ischemic heart disease patients].
    Lipnitskiĭ TN; Sheverda MG; Otkalenko IuK; Brovko AKh; Bogdanov EA
    Vrach Delo; 1986 Aug; (8):5-8. PubMed ID: 3776159
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of curantil and heparin on indices of microcirculatory and blood oxygen balance in ischemic heart disease].
    Denisiuk VI
    Vrach Delo; 1982; (10):26-9. PubMed ID: 7179876
    [No Abstract]   [Full Text] [Related]  

  • 5. [Carbohydrate metabolism in patients with ischemic heart disease and circulatory failure].
    Chursina TIa; Synchuk AN
    Vrach Delo; 1990 Sep; (9):16-8. PubMed ID: 2284753
    [No Abstract]   [Full Text] [Related]  

  • 6. [The use of mildronat in heart failure in patients with chronic ischemic heart disease].
    Sakharchuk II; Denisenko GT; Grushko VS; Bodaretskaia OI; Pishchalenko AN
    Vrach Delo; 1989 Sep; (9):21-3. PubMed ID: 2609613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of metabolically active agents in ischemic heart disease patients].
    Denisiuk VI
    Vrach Delo; 1986 Aug; (8):11-4. PubMed ID: 3776144
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of nerobol on the contractile capacity of the myocardium].
    Beĭ PI
    Klin Med (Mosk); 1972 Jan; 50(1):69-74. PubMed ID: 5020033
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prophylactic use of cardiac glycosides in patients with ischemic heart disease].
    Komarov FI; Rabkin IKh; Ol'binskaia LI; Kitaeva IT; Abugov AM
    Ter Arkh; 1974; 46(9):29-35. PubMed ID: 4439302
    [No Abstract]   [Full Text] [Related]  

  • 10. [Actihaemyl as adjuvant in cardiac therapy].
    Lordick H
    Munch Med Wochenschr; 1970 Feb; 112(7):298-300. PubMed ID: 5537795
    [No Abstract]   [Full Text] [Related]  

  • 11. [On heart therapy using Talusin].
    Fischer J
    Wien Med Wochenschr; 1967 Mar; 117(9):222-5. PubMed ID: 5588776
    [No Abstract]   [Full Text] [Related]  

  • 12. [Some principles of treatment of chronic circulatory insufficiency in the light of the modern concepts of its pathogenesis].
    Dovgiallo OG; Misiukevich II
    Ter Arkh; 1972 Aug; 44(8):110-4. PubMed ID: 5071573
    [No Abstract]   [Full Text] [Related]  

  • 13. [Some clinical observations on the use of a cardiokinetic extract of squill: proscillaridin A. Differences from other more commonly used glycosides].
    Luise A
    Minerva Med; 1967 Dec; 58(96):4286-9. PubMed ID: 6083290
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cardiotonic effect of Cd 412 (Peruvosid) on normal humans and subjects with cardiac insufficiency].
    Rivara Ruiz G; Dejo Bustios G; Alvarez Molteni R
    Rev Esp Cardiol; 1971; 24(2):191-9. PubMed ID: 4944701
    [No Abstract]   [Full Text] [Related]  

  • 15. [A current approach to treating chronic heart failure].
    Kipshidze NN; Lesina LG; Bokeriia ZD
    Vestn Akad Med Nauk SSSR; 1987; (11):81-6. PubMed ID: 3445690
    [No Abstract]   [Full Text] [Related]  

  • 16. [Anabolic agents in the therapy of chronic circulatory failure].
    Bondarenko IP
    Vrach Delo; 1982 Sep; (9):52-5. PubMed ID: 6758353
    [No Abstract]   [Full Text] [Related]  

  • 17. [Statistical evaluation of a cooperative study toward investigation of the effectiveness of the coronary stimulant dilazep in ischemic heart disease. 1. Epidemiological situation of coronary heart disease].
    Schneider VB; Feldmann U; von Brachel H; Schnitker J; Gelbhaar H
    Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1853-64. PubMed ID: 4480270
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of cardiac insufficiency with beta-methyldigoxin and the clinical significance of the blood concentration of digitalis glycosides].
    Tomov L; Tomov I; Orbetsov M; Todorova M; Visheva N
    Vutr Boles; 1977; 16(1):36-44. PubMed ID: 898908
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of various peripheral vasodilators on tissue circulation in patients with cardiac insufficiency].
    Aliev EB; Almazov II; Malyshev IuM; Makhatadze LN; Zhumambaeva RM
    Ter Arkh; 1982; 54(5):122-6. PubMed ID: 7101173
    [No Abstract]   [Full Text] [Related]  

  • 20. [Action of actodigin (AY-22,241) in patients with cardiac insufficiency and chronic auricular fibrillation or flutter].
    Bojorges R; Cárdenas M; Pastelín G; Mendez R
    Arch Inst Cardiol Mex; 1974; 44(4):615-23. PubMed ID: 4847978
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.